Q: How do I get involved?

Whether you’re a researcher, journalist, developer, or longevity enthusiast, we welcome your participation. Email us at contact@longevityone.org to explore partnerships, media opportunities, or to join our contributor network.

Question 1

What is LongevityOne?

Accepted Answer

LongevityOne is a global platform dedicated to curing human aging. We consolidate advanced research, emerging technology, and unified data to accelerate innovation in the longevity space. Our mission is to serve scientists, bio-hackers, and advocates with trustworthy resources and collaborative tools.

Question 2

Who founded LongevityOne?

Accepted Answer

LongevityOne was founded by Michael Peres, a serial entrepreneur and biomedical researcher with a background in Mathematics, Computer Science, and Jewish Studies. He is currently pursuing Biomedical Engineering to strengthen the technical foundation of LongevityOne’s work. Learn more about him at michaelperes.com.

Question 3

What makes LongevityOne different?

Accepted Answer

We don’t just report on breakthroughs — we unify them. LongevityOne acts as a central repository where research, news, tools, and contributors converge. By removing silos in the aging research ecosystem, we accelerate progress toward reversing age-related decline.

Question 4

Who is LongevityOne for?

Accepted Answer

Our platform is built for:Researchers in biotechnology, genetics, and agingMedical professionals and institutionsBio-hackers and health optimizersInvestors in life-extension technologiesPublic advocates for healthy aging

Question 5

What are your long-term goals?

Accepted Answer

Our core objective is to contribute to the development of a foundational cure for aging. We aim to reshape the human experience of aging by supporting breakthrough research, increasing public understanding, and fostering international collaboration over the next 15 years.

Question 6

How do I get involved?

Accepted Answer

Whether you&#8217;re a researcher, journalist, developer, or longevity enthusiast, we welcome your participation. Email us at contact@longevityone.org to explore partnerships, media opportunities, or to join our contributor network.

Longevity.Technology

Recent Articles

Mitophagy-promoting Parkinson’s drug funded into clinical trials

When longevity research hits a fiscal headwind

Longevity Center Warsaw

Zymo Research and biomodal partner to offer advanced multi-omic sequencing

Annovis Bio plans FDA meeting for PDD and confirms Phase 3 alignment for Alzheimer’s

Annovis biomarker data link Alzheimer’s co-pathology to faster cognitive decline in Parkinson’s

HCW Biologics initiates first‑in‑human trial of lead candidate HCW9302

Ochre Bio completes human liver functional genomics datasets with GSK

FAQS